Daten zu öffentlichen Aufträgen und Fördermitteln in Europa aus amtlichen Registern · Datenstand: 17. November 2026, tägliche Aktualisierung.

Förderprogramm · Vereinigte Staaten

Department of Health and Human Services SBIR

Department of Health and Human Services SBIR (Vereinigte Staaten): Aufrufe und Förderungen des Programms. 106 Aufrufe auf der Seite, davon 3 offen; Aufrufe starten meist im August. Datenstand: 17. November 2026, tägliche Aktualisierung.

Fördergeber: Department of Health and Human Services

Förderungen der letzten 24 Monate
0
Empfänger
0
Offene Aufrufe
3
Aufrufe auf der Seite
106

Aufrufe starten meist im August

Offene Aufrufe

Frühere Aufrufe

FörderaufrufStatusFrist
Development of devices, diagnostic technologies, or digital health tools for treatment, detection, and diagnosis of Pediatric Cancers and/or Rare Cancers. (Runde 07.2026 – 09.2026)Abgelaufen21. September 2026
Development of therapeutic or preventative technologies for treatment or prevention of Pediatric Cancers and/or Rare Cancers. (Runde 07.2026 – 09.2026)Abgelaufen21. September 2026
Small Business Transition Grant for New Entrepreneurs (R43/R44 Clinical Trial Required)Abgelaufen17. November 2025
Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional) (Runde 12.2024 – 11.2025)Abgelaufen17. November 2025
Miniaturization and Automation of Tissue Chip Systems (MATChS) (U43/U44 Clinical Trial Not Allowed)Abgelaufen17. November 2025
NeuroNEXT Small Business Innovation in Clinical Trials (U44 Clinical Trial Optional) (Runde 12.2024 – 11.2025)Abgelaufen17. November 2025
NINDS Exploratory Clinical Trials for Small Business (R43/R44 Clinical Trial Required) (Runde 12.2023 – 11.2025)Abgelaufen17. November 2025
NHLBI SBIR Phase IIB Small Market Awards to Accelerate the Commercialization of Technologies for Heart, Lung, Blood, and Sleep Disorders and Diseases (R44 Clinical Trial Optional) (Runde 01.2025 – 11.2025)Abgelaufen17. November 2025
Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional)Abgelaufen17. November 2025
NINDS Renewal Awards of SBIR Phase II Grants (Phase IIB) for Pre-Clinical Research (R44 Clinical Trial Not Allowed) (Runde 08.2024 – 11.2025)Abgelaufen17. November 2025
NHLBI SBIR Phase IIB Bridge Awards to Accelerate the Commercialization of Technologies for Heart, Lung, Blood, and Sleep Disorders and Diseases (R44 Clinical Trial Optional) (Runde 01.2025 – 11.2025)Abgelaufen17. November 2025
NIAID SBIR Phase II Clinical Trial Implementation Cooperative Agreement (U44 Clinical Trial Required) (Runde 04.2024 – 11.2025)Abgelaufen17. November 2025
NINDS Renewal Awards of SBIR Phase II Grants (Phase IIB) for Clinical Trials and Clinical Research (R44 Clinical Trial Optional) (Runde 08.2024 – 11.2025)Abgelaufen17. November 2025
NEI Small Business Innovation Research (SBIR) Cooperative Agreement for Early-Stage Clinical Trials with Greater than Minimal Risk (U44-Clinical Trial Required)Abgelaufen17. November 2025
Analytical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U44 Clinical Trial Optional)Abgelaufen17. November 2025
Small Business Transition Grant for New Entrepreneurs (R43/R44 Clinical Trial Not Allowed)Abgelaufen17. November 2025
Seeking Products to Address Social Needs impacting Substance Use Disorders (SUD) (R43/R44 Clinical Trial Optional)Abgelaufen17. November 2025
Clinical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U44 Clinical Trial Optional)Abgelaufen17. November 2025
Development of devices, diagnostic technologies, or digital health tools for treatment, detection, and diagnosis of Pediatric Cancers and/or Rare Cancers (Runde 05.2025 – 10.2025)Abgelaufen17. Oktober 2025
Development of therapeutic or preventative technologies for treatment or prevention of Pediatric Cancers and/or Rare Cancers. (Runde 05.2025 – 10.2025)Abgelaufen17. Oktober 2025
Development of devices, diagnostic technologies, or digital health tools for treatment, detection, and diagnosis of Pediatric Cancers and/or Rare Cancers. (Runde 06.2025 – 09.2025)Abgelaufen26. September 2025
Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional)Abgelaufen8. September 2025
SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1 Clinical Trial Required)Abgelaufen6. September 2025
Interactive Digital Media (IDM) Biomedical Science Resources for Pre-College Students and Teachers (SBIR) (R43/R44 Clinical Trial Not Allowed)Abgelaufen6. September 2025
PHS 2024-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required)Abgelaufen6. September 2025
Late-Stage Translation of Biomedical and Behavioral Research Results in Arthritis and Musculoskeletal and Skin Diseases from Academic/Non-profit Lab to Marketplace (SBIR [R43/R44] Clinical Trial Not Allowed)Abgelaufen6. September 2025
HEAL Commercialization Readiness Pilot (CRP) Program: Embedded Entrepreneurs for Small Businesses in Pain Management (SB1 Clinical Trial Not Allowed)Abgelaufen6. September 2025

Förderkalender

Förderungen für Projekte mit Beginn zwischen 17. November 2024 und 17. November 2026; Beträge in Euro zum Eurostat-Kurs des jeweiligen Jahres.

Fragen und Antworten

Department of Health and Human Services SBIR: Wann starten die Förderaufrufe?
Derzeit offen (3): SBIR/STTR Commercialization Readiness Pilot (CRP) Program (Parent SB1 Clinical Trial Opti… (6. April 2027), NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical… (6. April 2027) und NIH Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough Award (Par… (6. April 2027). Aufrufe starten meist im August.